Overview

Carnexiv was a prescription drug approved by the U.S. Food and Drug Administration (FDA) to control partial-onset seizures with complex symptomatology, generalized tonic-clonic seizures, and other generalized seizures. Carnexiv was also referred to by its drug name, carbamazepine.

Carnexiv was an anticonvulsant, or in other words, a drug used to prevent and control seizures. Carnexiv was a member of the dibenzazepine class of anticonvulsants. It was believed to work in cases of epilepsy by inhibiting nerve signals in the brain.

How was it taken?

Prescribing information stated that Carnexiv was administered as an intravenous injection (into your vein) every six hours. Carnexiv was indicated as a replacement for oral carbamazepine when oral administration is temporarily not feasible.

Carnexiv came in the form of a single-use vial.

Side effects

The FDA-approved label for Carnexiv listed common side effects including dizziness, sleepiness, blurred vision, double vision, headache, infusion-related reactions, and infusion site pain.

Rare but serious side effects listed for Carnexiv included severe allergic reactions, fetal harm, low blood sodium counts, low blood cell counts, liver damage, suicidal thoughts and behavior, and potentially fatal skin reactions.

For more details about this treatment, visit:

Carnexiv — Drugs.com